← Back to Search

Behavioural Intervention

Economic Support and Education Intervention for HIV Prevention in Young Adults (EMERGE Trial)

N/A

Recruiting

Led By Larissa Jennings Mayo-Wilson, PhD MHS

Research Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18-24

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up month 3, month 6, month 12, month 18, month 24

Awards & highlights

EMERGE Trial Summary

This trial will evaluate if a new intervention of text messages, education, mentorship, grants, and HIV prevention can improve economic stability and HIV prevention in 780 young adults.

Who is the study for?

This trial is for African-American young adults aged 18-24 living in Baltimore who have faced economic challenges in the past year, are sexually active, and can receive text messages on their mobile phones. It's not open to those under 18 or over 24, or anyone unwilling to consent to participate.Check my eligibility

What is being tested?

The study compares two groups: one just gets job alerts via texts (control), while the other also gets HIV prevention education, mentoring, a small grant, and texts about making smart choices to avoid HIV (intervention). Participants will be randomly placed into these groups.See study design

What are the potential side effects?

Since this intervention involves educational sessions and mentorship rather than medical treatments, traditional side effects like you'd see with medications aren't expected. However, participants may experience stress or anxiety related to program participation.

EMERGE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 24 years old.

EMERGE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ month 3, month 6, month 12, month 18, month 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~month 3, month 6, month 12, month 18, month 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3, month 6, month 12, month 18, month 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Other outcome measures

Mean condom self-efficacy score of participants in each group in the past six months

Mean economic self-efficacy score of participants in each group in the past six months

Mean economic stability score of participants in each group in the past six months

+10 more

EMERGE Trial Design

2Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Job announcements plus educational sessions, mentoring, a micro-grant, and behavioral economic text messages.

Group II: ControlExperimental Treatment1 Intervention

Job announcements only

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor

1,508 Previous Clinical Trials

4,190,045 Total Patients Enrolled

1 Trials studying Unprotected Sex

500 Patients Enrolled for Unprotected Sex

National Institute on Minority Health and Health Disparities (NIMHD)NIH

383 Previous Clinical Trials

1,215,579 Total Patients Enrolled

Adriana Parker, MPHStudy DirectorUniversity of North Carolina, Chapel Hill

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to participate in this clinical experiment?

"This medical investigation is searching for 780 individuals between 18-24 years of age who have engaged in unprotected intercourse. Prerequisites include being African American and sexually active within the past year."

Answered by AI

Are individuals of advanced age being considered for participation in this trial?

"This trial is only available to those in the age range of 18-24. However, there are 11 studies that accommodate individuals younger than 18 and 31 for seniors over 65."

Answered by AI

What is the total sample size of this investigation?

"Correct. According to clinicaltrials.gov, this medical investigation is presently accepting enrollees. The study was launched on September 19th 2023 and recently revised October 19th 2023. Approximately 780 individuals are needed from a single site for the trial's completion."

Answered by AI

Is enrollment for this research study currently open to participants?

"Affirmative. Clinicaltrials.gov contains information which indicates that this medical experiment is actively seeking participants and was initially posted on September 19th 2023, with the most recent update occurring October 19th of the same year. The study requires 780 individuals to be sourced from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Intervention for Sexual and Biomedical HIV Prevention in Vulnerable U.S. Young Adults

2023. "Intervention for Sexual and Biomedical HIV Prevention in Vulnerable U.S. Young Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06096324.